First Detection of WHO-validated artemisinin resistance Plasmodium falciparum K13 C469Y mutation in patient from Senegal.
Artemisinin-based Combination Therapies (ACTs) remain the first-line treatment for uncomplicated Plasmodium falciparum malaria in Senegal. The recent emergence of World Health Organization (WHO)-validated Pfkelch13 (K13) mutations associated with artemisinin partial resistance in Africa highlights the need for continuo...